General calculating model of the needs for allogenic stem cell transplantation for the patients with leukaemia and myelodysplastic syndrome in Vojvodina
Author(s) -
Svetlana Vojvodić,
Stevan Popović
Publication year - 2010
Publication title -
medicinski pregled
Language(s) - English
Resource type - Journals
eISSN - 1820-7383
pISSN - 0025-8105
DOI - 10.2298/mpns1006333v
Subject(s) - medicine , transplantation , incidence (geometry) , myelodysplastic syndromes , stem cell , disease , sibling , clone (java method) , pediatrics , bone marrow , psychology , developmental psychology , dna , physics , biology , optics , genetics
Allogeneic stem cell transplantation (SCT) application represents a treatment of choice that enables the eradication of malignant clone and chance for remedy of the patients with hematological diseases. Only 30-40% of the potential patients for allogeneic SCT have an HLA identical sibling, due to the fact that families in most of the developed countries are relatively small.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom